-
Mashup Score: 0
Weekly BIF achieved a similar efficacy compared with degludec despite higher fasting glucose targets in the BIF groups. Higher fasting glucose targets and lower glucose variability might have contributed to lower hypoglycaemia rates for BIF compared with degludec. These findings support continued development of BIF as a once-weekly insulin treatment for people with diabetes.
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4Making sense of weekly insulins - 1 year(s) ago
The current issue of The Lancet Diabetes & Endocrinology sees publication of a phase 2 study of the weekly insulin under development from Eli Lilly.1 Phase 2 studies have also been published from Novo Nordisk, who have further announced top-line results of a series of phase 3 studies to investors.2 Once-daily basal insulin is the standard starter regimen in people with type 2 diabetes,3 and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read Philip Home on: Making sense of weekly insulins https://t.co/dXGcPBwy1L #onceweeklyinsulin #T2D
-
-
Mashup Score: 2
Weekly BIF achieved a similar efficacy compared with degludec despite higher fasting glucose targets in the BIF groups. Higher fasting glucose targets and lower glucose variability might have contributed to lower hypoglycaemia rates for BIF compared with degludec. These findings support continued development of BIF as a once-weekly insulin treatment for people with diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Safety and efficacy of once-weekly basal #insulin Fc in people with type 2 #diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study https://t.co/yMEhhoYnIt #T2D #onceweeklyinsulin
-
-
Mashup Score: 1Making sense of weekly insulins - 1 year(s) ago
The current issue of The Lancet Diabetes & Endocrinology sees publication of a phase 2 study of the weekly insulin under development from Eli Lilly.1 Phase 2 studies have also been published from Novo Nordisk, who have further announced top-line results of a series of phase 3 studies to investors.2 Once-daily basal insulin is the standard starter regimen in people with type 2 diabetes,3 and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read the linked Comment by Philip Home: Making sense of #weekly #insulins https://t.co/dXGcPBwy1L #T2D #onceweeklyinsulin
-
-
Mashup Score: 2Making sense of weekly insulins - 1 year(s) ago
The current issue of The Lancet Diabetes & Endocrinology sees publication of a phase 2 study of the weekly insulin under development from Eli Lilly.1 Phase 2 studies have also been published from Novo Nordisk, who have further announced top-line results of a series of phase 3 studies to investors.2 Once-daily basal insulin is the standard starter regimen in people with type 2 diabetes,3 and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read Philip Home on: Making sense of weekly insulins https://t.co/dXGcPBwy1L #T2D #onceweeklyinsulin
-
-
Mashup Score: 0
Weekly BIF achieved a similar efficacy compared with degludec despite higher fasting glucose targets in the BIF groups. Higher fasting glucose targets and lower glucose variability might have contributed to lower hypoglycaemia rates for BIF compared with degludec. These findings support continued development of BIF as a once-weekly insulin treatment for people with diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
Safety and efficacy of once-weekly basal #insulin Fc in people with type 2 #diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study https://t.co/yMEhhoYVy1 #T2D #onceweeklyinsulin
-
-
Mashup Score: 0Making sense of weekly insulins - 1 year(s) ago
The current issue of The Lancet Diabetes & Endocrinology sees publication of a phase 2 study of the weekly insulin under development from Eli Lilly.1 Phase 2 studies have also been published from Novo Nordisk, who have further announced top-line results of a series of phase 3 studies to investors.2 Once-daily basal insulin is the standard starter regimen in people with type 2 diabetes,3 and…
Categories: Endocrinology, Latest HeadlinesTweet-
Also read Philip Home on: Making sense of #weekly #insulins https://t.co/dXGcPBwy1L #T2D #OnceWeeklyInsulin
-
-
Mashup Score: 0
Weekly BIF achieved a similar efficacy compared with degludec despite higher fasting glucose targets in the BIF groups. Higher fasting glucose targets and lower glucose variability might have contributed to lower hypoglycaemia rates for BIF compared with degludec. These findings support continued development of BIF as a once-weekly insulin treatment for people with diabetes.
Categories: Endocrinology, Latest HeadlinesTweet-
In the Current Issue: Safety and efficacy of once-weekly basal #insulin Fc in people with type 2 #diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study https://t.co/yMEhhoYVy1 #T2D #OnceWeeklyInsulin
-
Safety and efficacy of once-weekly basal #insulin Fc in people with type 2 #diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study https://t.co/yMEhhoYnIt #onceweeklyinsulin #T2D